Consensus Artivion, Inc. Deutsche Boerse AG

Stocks

CYL

US2289031005

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG Other stock markets 09:02:35 19/06/2026 +03			5-day change	1st Jan Change
18.30 ^EUR	-1.08%		+3.39%	-53.14%

06-15	Artivion Insider Sold Shares Worth $910,739, According to a Recent SEC Filing	MT
05-18	Artivion Closes $175 Million Acquisition of Endospan	MT

Evolution of the Average Target: Artivion, Inc.

Evolution of the Target Price: Artivion, Inc.

Changes in Analyst Recommendations: Artivion, Inc.

2dc8399e7247e37b.D6UweYz5dV_PzhIlYMILVAGdacEkQ-868bSb8U0q2GA.f5BpK_SaNjK6qmAUC7syMzSkGp5Nda1LgMLfiSlNq1Je7XQs9qhHaJi9fQ~0f7a09fbe60ed4e46ed5dbf9e1ebd3af

Analysts' recommendations: Artivion, Inc.

22/08/25	Needham Raises Price Target on Artivion to $50 From $45, Keeps Buy Rating	MT
08/08/25	Artivion Q2 revenue up 15%, beats analyst expectations	RE
08/11/24	Oppenheimer Raises Artivion Price Target to $32 From $30, Maintains Outperform Rating	MT
23/10/24	JMP Securities Initiates Artivion at Outperform With $33 Price Target	MT
09/08/24	Oppenheimer Adjusts Artivion Price Target to $30 From $25, Maintains Outperform Rating	MT
02/07/24	Lake Street Raises Price Target on Artivion to $30 From $28, Maintains Buy Rating	MT
07/05/24	Stifel Adjusts Price Target on Artivion to $25 From $22, Maintains Buy Rating	MT
07/05/24	Needham Adjusts Price Target on Artivion to $30 From $25, Maintains Buy Rating	MT
16/02/24	Stifel Raises Price Target on Artivion to $22 From $20, Maintains Buy Rating	MT
08/05/23	Morgan Stanley Adjusts Price Target on Artivion to $15 From $14, Maintains Equal-Weight Rating	MT
05/05/23	Needham Adjusts Price Target on Artivion to $26 From $23, Maintains Buy Rating	MT
04/11/22	Needham Adjusts Price Target on Artivion to $23 From $28, Maintains Buy Rating	MT
11/10/22	Morgan Stanley Trims Artivion's Price Target to $14 From $16, Reiterates Equalweight Rating	MT
27/09/22	Oppenheimer Adjusts Artivion's Price Target to $25 From $35, Maintains Outperform Rating	MT
26/09/22	Morgan Stanley Adjusts Artivion's Price Target to $16 from $23, Maintains Equalweight Rating	MT
26/09/22	Oppenheimer Adjusts Artivion Price Target to $25 From $35, Maintains Outperform Rating	MT
05/08/22	Needham Trims Artivion's Price Target to $28 From $29, Reiterates Buy Rating	MT
15/07/22	Morgan Stanley Adjusts Artivion's Price Target to $21 from $23, Keeps Equalweight Rating	MT
06/05/22	Needham Trims Artivion's Price Target to $29 From $30, Reiterates Buy Rating	MT
03/03/22	Stifel Starts Artivion at Buy With $30 Price Target	MT
18/02/22	Needham Adjusts Artivion's Price Target to $30 From $39 on 'Peer Multiple Compression;' Buy Rating Kept	MT
07/01/22	Morgan Stanley Lowers Price Target for CryoLife to $25 From $29, Maintains Equalweight Rating	MT
30/07/21	CRYOLIFE : Needham Adjusts CryoLife's Price Target to $39 From $38, Maintains Buy Rating	MT
15/07/21	CRYOLIFE : Morgan Stanley Starts CryoLife at Equal-Weight With $31 Price Target	MT
30/04/21	CRYOLIFE : Oppenheimer Adjusts CryoLife PT to $35 From $29, Maintains Outperform Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+31.82%
	MEDTRONIC PLC					+23.52%
	HOYA CORPORATION					+11.51%
	CENCORA, INC.					+28.97%
	BECTON, DICKINSON AND COMPANY					+25.5%
	MEDLINE INC.					+42.32%
	DEXCOM, INC.					+17.58%
	WEST PHARMACEUTICAL SERVICES, INC.					+9.4%
	TERUMO CORPORATION					+33.86%
	Average					+24.94%
	Weighted average by Cap.					+25.99%